Financial News

Financial Report: Sanofi

U.S. losses of exclusivity peak in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Financial Report: Sanofi 2Q Revenues: €8.2 billion (-6%) 2Q Earnings: €762 million (-26%) YTD Revenues: €16.1 billion (-7%) YTD Earnings: €1.8 billion (-74%) Comments: Pharmaceutical sales were up 2% to €6.3 billion driven by the Rare Blood Disorder and Immunology franchises, which was offset by declines in Diabetes and Established Rx Products. Sanofi Genzyme sales were up 14% driven by Dupixent and consolidation of Bioverativ. Vaccines sales were down 16% to €811 million related to the Pen...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters